PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Health and Biomedical Science, RMIT University, Bundoora, VIC 3083, Australia.\', \'Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia.\', \'School of Medicine, University of Tasmania, Launceston, TAS 7250, Australia.\', \'Department of Immunology and Pathology, Monash University, Melbourne, VIC 3004, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 896510.3390/ijms22168965
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 34445670
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all